Progyny (NASDAQ: PGNY)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Progyny (NASDAQ: PGNY) through any online brokerage.
Other companies in Progyny’s space includes: Humana (NYSE:HUM), HealthEquity (NASDAQ:HQY), Tekla World Healthcare (NYSE:THW), Molina Healthcare (NYSE:MOH) and Alignment Healthcare (NASDAQ:ALHC).
The latest price target for Progyny (NASDAQ: PGNY) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting PGNY to fall to within 12 months (a possible -91.11% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Progyny (NASDAQ: PGNY) is $45.01 last updated August 12, 2022, 8:00 PM UTC.
The next Progyny (PGNY) dividend date is projected to be Thursday, September 1, 2022.
Progyny’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Progyny.
Progyny is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.